Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

99 trials with published results (14%)

Research Maturity

456 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.9%

28 terminated out of 720 trials

Success Rate

94.2%

+7.7% vs benchmark

Late-Stage Pipeline

8%

60 trials in Phase 3/4

Results Transparency

22%

99 of 456 completed with results

Key Signals

99 with results94% success28 terminated

Data Visualizations

Phase Distribution

631Total
Not Applicable (513)
Early P 1 (4)
P 1 (23)
P 2 (31)
P 3 (32)
P 4 (28)

Trial Status

Completed456
Unknown84
Recruiting68
Active Not Recruiting35
Terminated28
Not Yet Recruiting23

Trial Success Rate

94.2%

Benchmark: 86.5%

Based on 456 completed trials

Clinical Trials (720)

Showing 20 of 20 trials
NCT06894498Recruiting

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT07569172Not ApplicableNot Yet Recruiting

Improved Child Nutrition and Development Through Social Transfers

NCT05291741Not ApplicableCompleted

Use of Very Low Calorie Diet Preoperatively to Bariatric Surgery

NCT07567937Not ApplicableCompletedPrimary

Investigation of the Effect of Rapid Weight Loss on Anaerobic Performance, Lactic Acid, and Creatine Kinase Values in Wrestlers

NCT02400359Phase 4Active Not Recruiting

Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

NCT00739362Phase 2Recruiting

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

NCT06776081Not ApplicableRecruiting

Adipocyte-Derived Extracellular Vesicles, Weight Loss, and Endothelial Function

NCT04036331Not ApplicableRecruitingPrimary

Dyad Plus Effectiveness/Feasibility

NCT07229170Recruiting

Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

NCT07015424Not ApplicableRecruiting

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

NCT07195708Not ApplicableNot Yet RecruitingPrimary

Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

NCT07276815Not ApplicableNot Yet RecruitingPrimary

OverStitch NXT Endoscopic Suture System

NCT07400588Phase 2Active Not Recruiting

Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

NCT04494048Recruiting

Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry

NCT01565317Not ApplicableCompleted

Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy

NCT07540754Phase 1Not Yet Recruiting

A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function

NCT07535892Not ApplicableNot Yet RecruitingPrimary

Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation

NCT06811324Phase 2Recruiting

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

NCT06351358Not ApplicableCompleted

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

NCT07144800Not ApplicableRecruiting

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

Scroll to load more

Research Network

Activity Timeline